v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2024   5,698,231      
Beginning balance at Dec. 31, 2024 $ 22,149 $ 6 $ 537,620 $ (122) $ (515,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   90,514      
Vesting of restricted stock units 0        
Stock-based compensation expense 519   519    
Unrealized loss on marketable securities (6)     (6)  
Net loss 282       282
Ending balance, shares at Mar. 31, 2025   5,788,745      
Ending balance at Mar. 31, 2025 22,944 $ 6 538,139 (128) (515,073)
Beginning balance, shares at Dec. 31, 2025   90,906,920      
Beginning balance at Dec. 31, 2025 186,290 $ 91 780,862 (109) (594,554)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   12,776      
Vesting of restricted stock units 0        
Exercise of pre-funded warrants (in shares)   3,400,000      
Exercise of pre-funded warrants 1 $ 3 (2)    
Stock-based compensation expense 2,413   2,413    
Unrealized loss on marketable securities (13)     (13)  
Net loss (20,241)       (20,241)
Ending balance, shares at Mar. 31, 2026   94,319,696      
Ending balance at Mar. 31, 2026 $ 168,450 $ 94 $ 783,273 $ (122) $ (614,795)